GAITHERSBURG, Md., Jan. 26 /PRNewswire/ -- Emergent BioSolutions Inc. announced today that it is the main event sponsor of the 4th Annual North American Phacilitate Vaccine Forum in Baltimore, MD, and that two of its executives will make presentations.
Chairman and Chief Executive Officer Fuad El-Hibri will speak to attendees on Wednesday, February 1 at 1:35 p.m. EST/10:35 a.m. PST. Mr. El-Hibri will discuss how to build a vaccine company in today’s challenging environment.
Also on Wednesday, February 1 at 11:25 a.m. EST/8:25 a.m. PST, Chief Scientific Officer Steven Chatfield will present on the role of new technologies in developing bacterial and viral vaccines for unmet needs.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is dedicated to the research, development, and manufacture of immunobiotics, novel products that harness the immune system to prevent and treat disease. These include products for prophylactic and therapeutic use against common infectious diseases and against biological weapons. The company currently employs more than 400 people with facilities in Gaithersburg and Frederick, Maryland; Lansing, Michigan; Berkshire, UK, and Munich, Germany. More information about Emergent BioSolutions and its subsidiaries can be found at http://www.ebsi.com .
Emergent BioSolutions Inc.
CONTACT: Kim Brennen Root of Emergent BioSolutions Inc., +1-517-327-1543,rootk@bioport.com
Web site: http://www.ebsi.com/